Mustafa Nuri Yenerel

Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia: Results of the First Randomized Phase III Trial

John C. Byrd, Peter Hillmen, Paolo Ghia et al. · Journal of Clinical Oncology · 2021 · 594 citations · Full text

Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study

Reyhan Diz Küçükkaya, Abdullah Hacıhanefioğlu, Mustafa Nuri Yenerel et al. · Blood · 2001 · 221 citations · Full text

Pesg PNH diagnosis, follow-up and treatment guidelines.

Fahri Şahin, Olga Meltem Akay, Mesut Ayer et al. · PubMed · 2016 · 49 citations · Full text

Disease Diagnosis, Urology, Study Group +14

First results of a head-to-head trial of acalabrutinib versus ibrutinib in previously treated chronic lymphocytic leukemia.

John C. Byrd, Peter Hillmen, Paolo Ghia et al. · Journal of Clinical Oncology · 2021 · 37 citations

Immunology, Pharmacotherapy, Ib Arm +17

Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuria

Phillip Scheinberg, Diego V. Clé, Jin Seok Kim et al. · American Journal of Hematology · 2024 · 34 citations · Full text